Ayala Pharmaceuticals Inc (ADXS)

[investisbest]

More and more, my feeling is that we'll never see the true potential of Advaxis as it's own entity. The more I think about it, the more I believe the next set of catalysts will be as follows:

1. EU partnership and/or approval
a. on partnership, price will climb to over 1B MC
b. on approval, price will double/triple from there

2. If #1 happens, Amgen will move aggressively to buy-out Advaxis. Hoping DOC and co. don't settle for anything under 8 billion.


This could all completely transpire sometime in 2018. The catalyst is approval in Europe and we'll get to see how it plays out from there. I just don't think Amgen will want to miss out on the potential in the 10's of billions if they buy Advaxis for under 10 billion.

All speculation of course, but it could be a real possibility if see approval, etc. Time will tell.